Schizophrenia Market Research Reports

Schizophrenia Market Research

Schizophrenia is a severe, lifelong brain disorder. People who have it may hear voices, see things that aren’t there or believe that others are reading or controlling their minds.

Research indicates that the global schizophrenia market was worth $6.7bn in 2009. The global Schizophrenia therapeutics market is forecast to decline with a CAGR of (3.7%) to reach $5.1bn by 2017. This decline in the market is primarily attributed to the release of generics of some of the leading products during the period 2011-2014. The therapeutic market for schizophrenia is expected to decline form 2011 till mid 2014 due to the patent expiry of major marketed drugs such as Zyprexa, Abilify, Seroquel and Geodon. However in the late 2014, the situation is set to improve. There is a huge unmet need in the current market in terms of safety and efficacy. Furthermore, a low treatment seeking rate and low patient compliance rate are likely to act as a barrier to market growth.

The Schizophrenia drug therapy market research report provides insight into the pipeline status of schizophrenia therapeutics by company and by stage, as well as a summary of the latest news and developments in this area. In addition to new developments and disease specific pipeline projects, the listed reports also contain extensive information in tabular format on a company’s full product pipeline, and products by phase of development with regard to the therapy area. The study also helps in keeping track of the industry-specific competitors and partners by better understanding their product pipeline.

The study basically aims at providing a comprehensive overview of the on-goings of the schizophrenia drugs & therapy market.

 



 

View More
TITLE Actions
Global Schizophrenia Drugs Market Insights, Forecast to 2025
Published in Jun 2019 | US $ 3900 Onwards | By QYResearch Group

Schizophrenia is a mental disorder characterized by abnormal social behavior and failure to understand reality. Common symptoms include false beliefs, unclear or confused thinking, hearing voices that others do not, reduced social engagement and emot...

Global Schizophrenia Therapeutics Market Size, Status and Forecast 2019-2025
Published in May 2019 | US $ 3900 Onwards | By QYResearch Group

Schizophrenia therapeutics are used as a standard treatment regimen for schizophrenia. It helps in reversing the low levels of dopamine and serotonin, thereby improving the patient's condition. The second-generation antipsychotic drugs segment...

Schizophrenia Drugs Market Research: Global Status & Forecast by Geography, Type & Application (2015-2025)
Published in May 2019 | US $ 2280 Onwards | By 99Strategy

According to 99Strategy, the Global Schizophrenia Drugs Market is estimated to reach xxx million USD in 2019 and projected to grow at the CAGR of xx% during the 2020-2025. The report analyses the global Schizophrenia Drugs market, the market size and...

Global Schizophrenia Therapeutic Market Size, Status and Forecast 2019-2025
Published in May 2019 | US $ 3900 Onwards | By QYResearch Group

Schizophrenia is a mental disorder characterized by abnormal behavior and failure to understand reality. The mainstay of schizophrenia treatment is antipsychotic medication, along with counselling, job training and social rehabilitation....

Global Schizophrenia Treatments Market Size, Status and Forecast 2019-2025
Published in May 2019 | US $ 3900 Onwards | By QYResearch Group

Schizophrenia is a mental disorder characterized by abnormal behavior and failure to understand reality. The schizophrenia treatment market is expected to witness a high growth over the forecast period owing to the increasing incidence of schi...

Schizophrenia Drug Market Insights 2019, Global and Chinese Analysis and Forecast to 2024
Published in Apr 2019 | US $ 3000 Onwards | By Prof Research

Schizophrenia Drug Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Schizophrenia Drug industry with a focus on the Chinese market. The report provides key statistics on the mar...

Global Schizophrenia Drugs Market Analysis 2013-2018 and Forecast 2019-2024
Published in Apr 2019 | US $ 2980 Onwards | By 99Strategy

Summary The global Schizophrenia Drugs market will reach xxx Million USD in 2019 and CAGR xx% 2019-2024. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and for...

Global Schizophrenia Drugs Market Data Survey Report 2013-2025
Published in Apr 2019 | US $ 1500 Onwards | By HeyReport

Summary The global Schizophrenia Drugs market will reach xxx Million USD in 2019 with CAGR xx% 2019-2025. The main contents of the report including: Global market size and forecast Regional market size, production data an...

Global Schizophrenia Drugs Market Research Report 2019
Published in Mar 2019 | US $ 2900 Onwards | By QYResearch Group

Schizophrenia is a mental disorder characterized by abnormal social behavior and failure to understand reality. Common symptoms include false beliefs, unclear or confused thinking, hearing voices that others do not, reduced social engagement and emot...

Global Schizophrenia Drugs Market Status and Future Forecast 2015-2024
Published in Mar 2019 | US $ 4500 Onwards | By 99Strategy

Summary The report forecast global Schizophrenia Drugs market to grow to reach xxx Million USD in 2019 with a CAGR of xx% during the period 2020-2024. The report offers detailed coverage of Schizophrenia Drugs industry a...

Global Schizophrenia Therapeutic Industry Market Research 2019
Published in Feb 2019 | US $ 2600 Onwards | By HJ Research

In this report, we analyze the Schizophrenia Therapeutic industry from two aspects. One part is about its production and the other part is about its consumption. In terms of its production, we analyze the production, revenue, gross margin of its main...

Global Schizophrenia Treatments Industry Market Research 2019
Published in Feb 2019 | US $ 2600 Onwards | By HJ Research

In this report, we analyze the Schizophrenia Treatments industry from two aspects. One part is about its production and the other part is about its consumption. In terms of its production, we analyze the production, revenue, gross margin of its main ...

Global Schizophrenia Therapeutics Industry Market Research 2019
Published in Feb 2019 | US $ 2600 Onwards | By HJ Research

In this report, we analyze the Schizophrenia Therapeutics industry from two aspects. One part is about its production and the other part is about its consumption. In terms of its production, we analyze the production, revenue, gross margin of its mai...

Cognitive Impairment Associated With Schizophrenia (CIAS) - Pipeline Review, H1 2019
Published in Feb 2019 | US $ 2000 Onwards | By Global Markets Direct

Cognitive Impairment Associated With Schizophrenia (CIAS) - Pipeline Review, H1 2019 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Cognitive Impairment Associated With Schizophre...

Schizophrenia Therapeutics Market Insights 2019, Global and Chinese Analysis and Forecast to 2024
Published in Jan 2019 | US $ 3000 Onwards | By Prof Research

Schizophrenia Therapeutics Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Schizophrenia Therapeutics industry with a focus on the Chinese market. The report provides key stati...

Schizophrenia Drugs Market Insights 2019, Global and Chinese Analysis and Forecast to 2024
Published in Jan 2019 | US $ 3000 Onwards | By Prof Research

Schizophrenia Drugs Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Schizophrenia Drugs industry with a focus on the Chinese market. The report provides key statistics on the m...

Schizophrenia Drugs - Global Market Research and Forecast, 2015-2025
Published in Jan 2019 | US $ 2200 Onwards | By HeyReport

Summary The Schizophrenia Drugs report provides an independent information about the Schizophrenia Drugs industry supported by extensive research on factors such as industry segments size & trends, inhibitors, dynamics, drivers, opport...

Cognitive Impairment Associated With Schizophrenia (CIAS) - Pipeline Insight, 2019
Published in Jan 2019 | US $ 1500 Onwards | By Delve Insight

"Cognitive Impairment Associated With Schizophrenia (CIAS) - Pipeline Insight, 2019” report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Cognitive Impairment Associ...

Schizophrenia - Epidemiology Forecast to 2028
Published in Jan 2019 | US $ 3250 Onwards | By Delve Insight

DelveInsight's "Schizophrenia - Epidemiology Forecast, 2028” report provides a comprehensive analysis of the Schizophrenia epidemiology, providing the historical and forecasted data for the 7MM during the forecast period from 2016-2028. ...

Schizophrenia - Market Insight, Epidemiology and Market Forecast - 2028
Published in Jan 2019 | US $ 6250 Onwards | By Delve Insight

DelveInsight's "Schizophrenia - Market Insight, Epidemiology and Market Forecast - 2028" report provides a detailed analysis of the Schizophrenia epidemiology and market outlook for the 7MM. Markets Covered - United States...

We are on:

Need Help?

Avail 15% Discount, Use JUNE15 Coupon Code